Anthropic is operating a lab that conducts biology experiments
(techcrunch.com)
1.
2.
Novo Nordisk Will Use Anthropic’s Claude for Drug Research
(feeds.content.dowjones.io)
3.
Does Novo Nordisk’s slimmed down rebrand signal a new era of DTC revivalism?
(feeds.feedburner.com)
4.
Novo Nordisk Breach Highlights Software Development Pipeline Risk
(darkreading.com)
5.
Novo Nordisk Breach Exposes Software Development Pipeline Risk
(darkreading.com)
6.
Leak confirms OpenAI is testing a ChatGPT for Science subscription
(bleepingcomputer.com)
8.
Pharma giant Novo Nordisk discloses breach of clinical trials data
(bleepingcomputer.com)
9.
10.
Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
11.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
12.
How to secure philanthropic funding in a competitive climate
(feeds.nature.com)
14.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
15.
Novo Nordisk and OpenAI Partner to Speed Drug Discovery
(feeds.content.dowjones.io)
18.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
19.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
20.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
21.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
22.
23.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
25.
Ozempic just released its own version of the iconic Mac vs. PC ad
(feeds.feedburner.com)
28.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
(news.ycombinator.com)
29.
FDA Approves Pill Version of Wegovy
(wired.com)
30.
Today's top topics:
openai
anthropic
apple
ai safety
google
iphone 18 pro
artificial intelligence
ios 27
dario amodei
nvidia